Tuesday 42115 Fast Moving Stocks (OSLH) (PPCH) (NGCG) (CTIX) (PPHM)

We hope all of our readers and visitors are having a profitable Tuesday. As always, we must start off with one of the day’s biggest movers, OSL Holdings Inc. (OSLH). So far today OSLH has traded over 58731579 shares, slightly above its 30 day average volume. The stock opened at 0.02 this morning. OSLH is now sitting at 0.01 as we type this. The latest press release from OSLH is: OSL Holdings Announces Intent to Enter into a JV & Licensing Agreement with Cheryl Shuman. Investors will surely be watching OSLH over the next few days.

Another fast moving stock is Propanc Health Group Corporation (PPCH). As we monitor PPCH, we’ve watched over 28360636 shares trade today, which is greater than its 30 day average volume of 17928800. The last PR traders have seen from PPCH reads: Propanc to Settle Outstanding Convertible Debts.

New Generation Consumer Group, Inc. (NGCG) has also caught the attention of daytraders today. NGCG is currently trading at 0.03, which puts the company’s value at $40.21K. So far the stock has traded 19977059 shares, slightly higher than its 30 day average volume of 3846170.

Pull up the chart on CTIX and you will see why it deserves its spot in the media. Currently priced at about 3.16 per share, Cellceutix Corporation (CTIX) has traded over 171282 shares today, slightly below its 30 day average volume of about 248353. The stock opened around 3.15 this morning. The latest press release from CTIX is Cellceutix Provides Corporate Update. We will be sure to watch CTIX closely over the next week.

Lastly, we must take a look at what happened to Peregrine Pharmaceuticals, Inc. (PPHM) today. PPHM has traded over 522536 shares today and is currently trading at 1.44. The stock opened around 1.43 this morning. Investors will surely be watching PPHM closely over the next few days.

_______________________________________________________________________________________

Relevant Headlines:   

OSL Holdings Announces Intent to Enter into a JV & Licensing Agreement with Cheryl Shuman

Propanc to Settle Outstanding Convertible Debts

New Generation Consumer Group, Inc. Announces H420 Waters

Cellceutix Provides Corporate Update

Preclinical Data Presented at AACR Demonstrate Synergistic Anti-Tumor Effects of Peregrine Pharmaceuticals’ Phosphatidylserine (PS)-Targeting Antibodies With Immune Checkpoint Inhibitors in Models of Melanoma and Breast Cancer

_______________________________________________________________________________________

About www.actualgains.com: We send you custom, well-thought-out penny stock profiles right to your inbox free of charge. We are one of the only penny stock newsletters who wait carefully before sending timely alerts. We examine technical analysis of penny stocks and huge market moves that could profit investors(like the current medical marijuana penny stock rally!) Subscribe free today. Do not miss our next report.                                                                                                                                                                                                                                     Disclaimer: This is not an offer to buy or sell securities. Information or opinions are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. Neither ActualGains.com nor any of its employees, affiliates, subsidiaries or family members are registered investment advisors or registered stock brokers and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site. Do not buy any stock ActualGains.com mentions. We are not liable for any investment decisions by our readers. By way of visit to this webpage, you agree to indemnify and hold harmless ActualGains.com, its employees and owners against any and all actions, claims, damages, obligations, losses, proceedings, expenses and liabilities.